Europe Cancer Biomarkers Market Research Report Forecast 2017-2021

May 2017 | 126 pages | ID: EEF59D28004EN
S&P Consulting

Abstracts

The Europe Cancer Biomarkers Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cancer Biomarkers industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Biomarkers market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Cancer Biomarkers Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Bruker Daltonics
Abbott
Agilent
BDI
OncoThyreon
Biomoda
Asuragen
Beckman Coulter
BioCurex

Europe Cancer Biomarkers Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Cancer Biomarkers Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 CANCER BIOMARKERS MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Classification of Cancer Biomarkers
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cancer Biomarkers
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Biomarkers Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Cancer Biomarkers (2012-2021)
  1.5.1 Europe Cancer Biomarkers Sales and Growth Rate (2012-2021)
  1.5.2 Europe Cancer Biomarkers Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON CANCER BIOMARKERS INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 CANCER BIOMARKERS MANUFACTURING COST ANALYSIS

3.1 Cancer Biomarkers Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cancer Biomarkers

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cancer Biomarkers Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE CANCER BIOMARKERS MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Cancer Biomarkers Market Competition by Manufacturers
  5.1.1 Europe Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Cancer Biomarkers (Volume and Value) by Type
  5.2.1 Europe Cancer Biomarkers Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Cancer Biomarkers Revenue and Market Share by Type (2012-2017)
5.3 Europe Cancer Biomarkers (Volume and Value) by Countries
  5.3.1 Europe Cancer Biomarkers Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Cancer Biomarkers Revenue and Market Share by Countries (2012-2017)
5.4 Europe Cancer Biomarkers (Volume) by Application

6 GERMANY CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Cancer Biomarkers Sales and Value (2012-2017)
  6.1.1 Germany Cancer Biomarkers Sales and Growth Rate (2012-2017)
  6.1.2 Germany Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Cancer Biomarkers Sales Price Trend (2012-2017)
6.2 Germany Cancer Biomarkers Sales and Market Share by Manufacturers
6.3 Germany Cancer Biomarkers Sales and Market Share by Type
6.4 Germany Cancer Biomarkers Sales and Market Share by Application

7 FRANCE CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

7.1 France Cancer Biomarkers Sales and Value (2012-2017)
  7.1.1 France Cancer Biomarkers Sales and Growth Rate (2012-2017)
  7.1.2 France Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  7.1.3 France Cancer Biomarkers Sales Price Trend (2012-2017)
7.2 France Cancer Biomarkers Sales and Market Share by Manufacturers
7.3 France Cancer Biomarkers Sales and Market Share by Type
7.4 France Cancer Biomarkers Sales and Market Share by Application

8 UK CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

8.1 UK Cancer Biomarkers Sales and Value (2012-2017)
  8.1.1 UK Cancer Biomarkers Sales and Growth Rate (2012-2017)
  8.1.2 UK Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  8.1.3 UK Cancer Biomarkers Sales Price Trend (2012-2017)
8.2 UK Cancer Biomarkers Sales and Market Share by Manufacturers
8.3 UK Cancer Biomarkers Sales and Market Share by Type
8.4 UK Cancer Biomarkers Sales and Market Share by Application

9 RUSSIA CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Cancer Biomarkers Sales and Value (2012-2017)
  9.1.1 Russia Cancer Biomarkers Sales and Growth Rate (2012-2017)
  9.1.2 Russia Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Cancer Biomarkers Sales Price Trend (2012-2017)
9.2 Russia Cancer Biomarkers Sales and Market Share by Manufacturers
9.3 Russia Cancer Biomarkers Sales and Market Share by Type
9.4 Russia Cancer Biomarkers Sales and Market Share by Application

10 ITALY CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Cancer Biomarkers Sales and Value (2012-2017)
  10.1.1 Italy Cancer Biomarkers Sales and Growth Rate (2012-2017)
  10.1.2 Italy Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Cancer Biomarkers Sales Price Trend (2012-2017)
10.2 Italy Cancer Biomarkers Sales and Market Share by Manufacturers
10.3 Italy Cancer Biomarkers Sales and Market Share by Type
10.4 Italy Cancer Biomarkers Sales and Market Share by Application

11 SPAIN CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Cancer Biomarkers Sales and Value (2012-2017)
  11.1.1 Spain Cancer Biomarkers Sales and Growth Rate (2012-2017)
  11.1.2 Spain Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Cancer Biomarkers Sales Price Trend (2012-2017)
11.2 Spain Cancer Biomarkers Sales and Market Share by Manufacturers
11.3 Spain Cancer Biomarkers Sales and Market Share by Type
11.4 Spain Cancer Biomarkers Sales and Market Share by Application

12 BENELUX CANCER BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Cancer Biomarkers Sales and Value (2012-2017)
  12.1.1 Benelux Cancer Biomarkers Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Cancer Biomarkers Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Cancer Biomarkers Sales Price Trend (2012-2017)
12.2 Benelux Cancer Biomarkers Sales and Market Share by Manufacturers
12.3 Benelux Cancer Biomarkers Sales and Market Share by Type
12.4 Benelux Cancer Biomarkers Sales and Market Share by Application

13 EUROPE CANCER BIOMARKERS MANUFACTURERS ANALYSIS

13.1 Bruker Daltonics
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Abbott
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Agilent
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 BDI
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 OncoThyreon
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Biomoda
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Asuragen
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Beckman Coulter
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 BioCurex
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE CANCER BIOMARKERS MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Cancer Biomarkers Market Forecast by Type (2017-2021)
15.9 Europe Cancer Biomarkers Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Biomarkers
Table Classification of Cancer Biomarkers
Figure Europe Sales Market Share of Cancer Biomarkers by Type in 2015
Table Application of Cancer Biomarkers
Figure Europe Sales Market Share of Cancer Biomarkers by Application in 2015
Figure Germany Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure France Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure UK Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure Russia Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure Italy Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure Spain Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Figure Europe Cancer Biomarkers Sales and Growth Rate (2012-2021)
Figure Europe Cancer Biomarkers Revenue and Growth Rate (2012-2021)
Table Europe Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Cancer Biomarkers Sales Share by Manufacturers
Table Europe Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 Europe Cancer Biomarkers Revenue Share by Manufacturers
Table Europe Cancer Biomarkers Sales and Market Share by Type (2012-2017)
Table Europe Cancer Biomarkers Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Biomarkers by Type (2012-2017)
Figure Europe Cancer Biomarkers Sales Growth Rate by Type (2012-2017)
Table Europe Cancer Biomarkers Revenue and Market Share by Type (2012-2017)
Table Europe Cancer Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Biomarkers by Type (2012-2017)
Figure Europe Cancer Biomarkers Revenue Growth Rate by Type (2012-2017)
Table Europe Cancer Biomarkers Sales and Market Share by Countries (2012-2017)
Table Europe Cancer Biomarkers Sales Share by Countries (2012-2017)
Figure Sales Market Share of Cancer Biomarkers by Countries (2012-2017)
Table Europe Cancer Biomarkers Revenue and Market Share by Countries (2012-2017)
Table Europe Cancer Biomarkers Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Cancer Biomarkers by Countries (2012-2017)
Table Europe Cancer Biomarkers Sales and Market Share by Application (2012-2017)
Table Europe Cancer Biomarkers Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Biomarkers by Application (2012-2017)
Figure Germany Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure Germany Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure Germany Cancer Biomarkers Sales Price Trend (2012-2017)
Table Germany Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Biomarkers Sales by Type (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Germany Cancer Biomarkers Sales by Application (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure France Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure France Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure France Cancer Biomarkers Sales Price Trend (2012-2017)
Table France Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table France Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table France Cancer Biomarkers Sales by Type (2015 and 2016)
Table France Cancer Biomarkers Market Share by Type (2015 and 2016)
Table France Cancer Biomarkers Sales by Application (2015 and 2016)
Table France Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure UK Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure UK Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure UK Cancer Biomarkers Sales Price Trend (2012-2017)
Table UK Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Biomarkers Sales by Type (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Type (2015 and 2016)
Table UK Cancer Biomarkers Sales by Application (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Russia Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure Russia Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure Russia Cancer Biomarkers Sales Price Trend (2012-2017)
Table Russia Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Biomarkers Sales by Type (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Russia Cancer Biomarkers Sales by Application (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Italy Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure Italy Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure Italy Cancer Biomarkers Sales Price Trend (2012-2017)
Table Italy Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Biomarkers Sales by Type (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Italy Cancer Biomarkers Sales by Application (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Spain Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure Spain Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure Spain Cancer Biomarkers Sales Price Trend (2012-2017)
Table Spain Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Biomarkers Sales by Type (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Spain Cancer Biomarkers Sales by Application (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Benelux Cancer Biomarkers Sales and Growth Rate (2012-2017)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate (2012-2017)
Figure Benelux Cancer Biomarkers Sales Price Trend (2012-2017)
Table Benelux Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Biomarkers Sales by Type (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Benelux Cancer Biomarkers Sales by Application (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Application (2015 and 2016)
Table Bruker Daltonics Basic Information List
Table Bruker Daltonics Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bruker Daltonics Cancer Biomarkers Sales Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Cancer Biomarkers Sales Market Share (2012-2017)
Table Agilent Basic Information List
Table Agilent Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Agilent Cancer Biomarkers Sales Market Share (2012-2017)
Table BDI Basic Information List
Table BDI Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Table BDI Cancer Biomarkers Sales Market Share (2012-2017)
Table OncoThyreon Basic Information List
Table OncoThyreon Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Figure OncoThyreon Cancer Biomarkers Sales Market Share (2012-2017)
Table Biomoda Basic Information List
Table Biomoda Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biomoda Cancer Biomarkers Sales Market Share (2012-2017)
Table Asuragen Basic Information List
Table Asuragen Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Asuragen Cancer Biomarkers Sales Market Share (2012-2017)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Table Beckman Coulter Cancer Biomarkers Sales Market Share (2012-2017)
Table BioCurex Basic Information List
Table BioCurex Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BioCurex Cancer Biomarkers Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure Germany Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure Germany Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Figure France Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure France Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Figure UK Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure UK Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure Russia Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure Italy Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure Spain Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Cancer Biomarkers Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate Forecast (2017-2021)
Table Europe Cancer Biomarkers Sales Forecast by Type (2017-2021)
Table Europe Cancer Biomarkers Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bruker Daltonics
Abbott
Agilent
BDI
OncoThyreon
Biomoda
Asuragen
Beckman Coulter
BioCurex